Clinical trial
Comparison of Combination Chemotherapy Regimens in Treating Patients With…
NCT00066274 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00066274 |
|---|---|
| Title | Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer |
| Official title | Randomized Phase II Study Evaluating Three Chemotherapies: [Irinotecan + Oxaliplatin (Irinox)], [Irinotecan + LV5FU2] and [Oxaliplatin + LV5FU2] as First Intention Treatment in Subjects With Metastatic Colorectal Cancer |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | FOLFIRI regimen, FOLFOX regimen, fluorouracil, irinotecan hydrochloride, leucovorin calcium, oxaliplatin |
| Start date | Jul 23, 2002 |
| Primary completion | Nov 4, 2005 |
| Completion | Apr 1, 2007 |
| First posted | Aug 7, 2003 |
| Last update posted | Mar 2, 2021 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: